In recent years, supplements based on Serenoa repens have become increasingly important in the nutraceutical market dedicated to men's health. The lipid extract obtained from the fruits of Serenoa repens is widely used in formulations aimed at supporting prostate function and urinary tract wellness, one of the main application areas in phytotherapy.

Despite its well-recognized functional value, Serenoa repens presents several technological challenges that can complicate its integration into modern nutraceutical formulations. The extract is characterized by a viscous lipid phase sensitive to oxidation, and it also has a strong organoleptic profile that can negatively influence the sensory experience of the finished product.

In this context, FlowActives® microencapsulation technology developed by IPS represents an effective solution to improve stability, processability, and overall formulation quality.

Technological challenges of Serenoa repens extract

Serenoa repens lipid extracts contain a complex mixture of free fatty acids and phytosterols, key components responsible for the functional activity of the ingredient. However, their lipid nature introduces several formulation limitations:

• oxidation sensitivity, leading to possible degradation over time
  • oily or semi-liquid consistency, difficult to handle in industrial processes
  • strong odor and taste, potentially affecting product palatability
  • poor flowability, complicating dosing in capsules or sachets

These aspects can make the production of solid nutraceutical supplements more challenging and may reduce the stability of the final product.

The role of FlowActives® microencapsulation

Thanks to FlowActives® technology, IPS can convert Serenoa repens lipid extract into solid, highly flowable microcapsules obtained through a controlled coacervation microencapsulation process.

During this process, the extract is encapsulated within a flexible biopolymeric matrix, providing protective functions.

This structure allows:

• protection of the lipid extract from oxidation, helping maintain ingredient quality over time
  • stabilization of the oily phase, converting it into a technically manageable powder
  • improved compatibility with complex nutraceutical formulations
  • preservation of the extract’s functional characteristics within the final product

The result is a microencapsulated ingredient that preserves the phytotherapeutic identity of Serenoa repens while improving its technological performance.

Organoleptic benefits and process advantages

Beyond protecting the extract, microencapsulation also provides important formulation and sensory benefits.

FlowActives® microcapsules offer:

• attenuated odor and taste, improving product organoleptic quality
  • high flowability, facilitating dosing and blending operations
  • better distribution uniformity of the ingredient within formulations
  • compatibility with multiple dosage forms, including capsules, powders, and sachets

These characteristics make Serenoa repens easier to integrate into advanced phytotherapeutic formulations without requiring significant modifications to manufacturing processes.

Toward a new generation of phytotherapeutic supplements

The combination of traditional phytotherapy and advanced technological solutions is now one of the main drivers of innovation in the nutraceutical sector.

Through FlowActives® technology, IPS supports companies in developing microencapsulated ingredients that improve stability, processability, and sensory quality, while preserving the value of natural extracts.

In the case of Serenoa repens, microencapsulation helps overcome many of the technical limitations associated with lipid extracts, opening new opportunities for the development of more stable, reliable, and technologically advanced nutraceutical products.

Note: This article is provided for informational purposes only and does not substitute professional medical advice.